VR Logo

Scopus BioPharma Inc. (SCPS) download report


Healthcare | Biotechnology & Pharma Research

Scopus BioPharma Inc. (SCPS) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases.

IPO Date: 16-Dec-2020

Vice Chairman, Sec. & Treasurer: Mr. Robert J. Gibson

Sr. Advisor & Director: Mr. Ira Scott Greenspan

Listing: NASDAQ: SCPS

Country: United States

Headquarters: New York, NY

Website: https://scopusbiopharma.com

Key Facts

Market cap: $7.95 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-28.21 Mln

Cash: $7.94 Mln

Total Debt: $0.00 Mln

Insider's Holding: 50.66%

Liquidity: Low

52 Week range: $0.34 - 7.25

Shares outstanding: 21,094,300

5 Years Aggregate:

  • CFO: $-17.05 Mln
  • EBITDA: $-41.16 Mln
  • Net Profit: $-41.19 Mln

Stock Performance

Time Period Scopus BioPharma (SCPS) S&P BSE Sensex S&P Small-Cap 600
YTD-75.65-9.18-18.78
1 month4.76-4.78-8.00
3 months-42.39-9.66-13.65
1 Year-94.420.81-17.19
3 Years--10.336.10
5 Years--11.345.87
10 Years--11.749.84
As on 01-Jul-2022
Year Scopus BioPharma (SCPS) S&P Small-Cap 600 S&P BSE Sensex
2021-88.9825.2721.99